Detailed answers about DR DANIEL J QUEMBY CLINICAL CONSULTANCY LIMITED, including incorporation, status, business activity, and accounts information.
When was DR DANIEL J QUEMBY CLINICAL CONSULTANCY LIMITED founded?
DR DANIEL J QUEMBY CLINICAL CONSULTANCY LIMITED was officially incorporated on 17 February 2024 and is registered under company number 15496420. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is DR DANIEL J QUEMBY CLINICAL CONSULTANCY LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of DR DANIEL J QUEMBY CLINICAL CONSULTANCY LIMITED?
DR DANIEL J QUEMBY CLINICAL CONSULTANCY LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does DR DANIEL J QUEMBY CLINICAL CONSULTANCY LIMITED do?
DR DANIEL J QUEMBY CLINICAL CONSULTANCY LIMITED operates in the following sector: 86220 - Specialists medical practice activities. This provides insight into the company's primary business activity and industry focus.
What is DR DANIEL J QUEMBY CLINICAL CONSULTANCY LIMITED's registered address?
The registered office address of DR DANIEL J QUEMBY CLINICAL CONSULTANCY LIMITED is C/O ECHO TAX SPACES MANCHESTER, PETER HOUSE, OXFORD STREET, MANCHESTER, UNITED KINGDOM, M1 5AN. This is the official address filed with Companies House for legal and statutory correspondence.
Is DR DANIEL J QUEMBY CLINICAL CONSULTANCY LIMITED financially stable?
The most recent accounts for DR DANIEL J QUEMBY CLINICAL CONSULTANCY LIMITED were made up to 28 February 2025, filed as TOTAL EXEMPTION FULL. Next accounts are due by 30 November 2026.